Integra LifeSciences borrows $700 million delayed-draw term loan A

By Angela McDaniels

Tacoma, Wash., Oct. 2 – Integra LifeSciences Holdings Corp. borrowed its $700 million delayed-draw term loan A in full on Tuesday, according to an 8-K filing with the Securities and Exchange Commission.

The company established the term loan on March 31, 2017.

Proceeds, along with revolver borrowings, were used to fund Integra’s acquisition of Johnson & Johnson’s Codman Neurosurgery business for $1.05 billion in cash.

The credit facility will mature on Dec. 7, 2021.

Bank of America, NA is the administrative agent.

Integra LifeSciences is a medical technology company based in Plainsboro, N.J. Codman Neurosurgery is a provider of devices focused on advanced hydrocephalus, neuro-critical care and operative neurosurgery.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.